Intelligent Bio Solutions...

NASDAQ: INBS · Real-Time Price · USD
1.45
-0.03 (-2.03%)
At close: Aug 15, 2025, 11:58 AM

Intelligent Bio Solutions Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
2.94M 3.03M 3.19M 3.11M 2.83M 2.46M 2.05M 1.26M 813.74K 356.68K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1.21M 1.47M 1.65M 1.69M 2.17M 1.95M 1.49M 930.2K 536.64K 112.64K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
1.73M 1.56M 1.54M 1.43M 659.64K 514.2K 559K 637.99K 588.41K 555.36K 311.32K n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-10.35M -10.76M -10.48M -10.28M -10.17M -9.78M -9.92M -8.62M -8M -6.78M -8.12M -8.34M -7.1M -8.9M -6.35M -5.57M -5.22M -2.26M -3.05M
Interest Income
163K 155.95K 137.52K 84.82K 14.38K 4.25K 2.21K 9.68K 13.04K 15.44K 17.43K 14.43K 16.64K 21.37K 18.33K 13.81K 8.14K 532.00 125.00
Pretax Income
-10.27M -10.72M -10.44M -10.19M -10.07M -13.43M -11.88M -10.66M -10.08M -5.07M -8.11M -8.33M -7.1M -8.89M -7.42M -7.06M -6.67M -3.64M -3.5M
Net Income
-10.26M -10.7M -10.42M -10.16M -10.03M -13.4M -11.85M -10.63M -10.05M -5.04M -8.08M -8.31M -7.08M -8.87M -7.4M -7.04M -6.63M -3.62M -3.47M
Selling & General & Admin
8.84M 8.86M 8.75M 9.26M 9.02M 8.49M 9.03M 8.03M 7.06M 6.28M 5.04M 4.92M 4.6M 4.5M 4.36M 3.7M 3.08M 2.15M 2.5M
Research & Development
2.21M 2.68M 2.52M 1.67M 1.05M 879.36K 532.1K 507.42K 1.07M 1.19M 3.83M 3.85M 4.47M 6.21M 3.91M 3.84M 2.58M 361.12K 513.96K
Other Expenses
552.45K 552.45K 380.91K 206.62K 192.77K 474.07K 602.6K 291.28K 31.66K -442.14K -748.47K -437.15K -1.98M -1.82M -1.93M -1.98M -436.85K -402.56K -119.56K
Operating Expenses
11.6M 12.08M 11.79M 11.47M 10.6M 10.18M 10.37M 8.83M 8.16M 7.02M 8.12M 8.34M 7.1M 8.9M 6.35M 5.57M 5.21M 2.09M 2.88M
Interest Expense
105.38K 133.05K 152.02K 167.14K 172.17K 215.62K 259.92K 223.53K 166.6K 84.7K 8.6K 7.54K 7.25K 21.59K 1.01M 1.09M 1.17M 1.23M 394.06K
Selling & Marketing Expenses
n/a n/a n/a n/a -1.26M -1.26M -1.26M -1.26M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
12.13M 13.19M 13.75M 13.48M 13.02M 12.06M 11.8M 9.69M 8.7M 7.14M 8.12M 8.34M 8.56M 10.39M 7.84M 7.12M 5.39M 2.24M 3.03M
Income Tax Expense
7.33K -1.77K -9.09K -9.09K -9.09K -8.11K -8.11K -13.9K -23.92K -24.7K -28.52K -27.93K -15.13K -21.1K -23.7K -22.91K -25.68K -12.15K -22.44K
Shares Outstanding (Basic)
5.77M 4.54M 3.18M 3.04M 2.08M 949.66K 1.95M 1M 1.11M 75.69K 1.24M 744.5K 744.5K 744.13K 700.31K 679.11K 589.79K 718.56K 719.16K
Shares Outstanding (Diluted)
5.77M 4.54M 3.81M 3.04M 2.08M 949.66K 1.95M 1M 1.11M 75.69K 744.5K 744.5K 744.5K 744.13K 700.31K 679.11K 589.79K 718.56K 719.16K
EPS (Basic)
-4.38 -5.37 -6.94 -7.73 -8.51 -13.95 -12.44 -11.91 -12.73 -8.01 -13.03 -13.53 -11.8 -74.45 -74.39 -74.92 -74.59 -12.18 -45.69
EPS (Diluted)
-3.39 -4.38 -5.95 -17.73 -41.31 -108.55 -216.88 -223.6 -231.77 -165.25 -60.43 -43.68 -11.8 -74.45 -74.39 -74.92 -74.59 -12.18 -45.69
EBITDA
-8.99M -9.38M -9.09M -8.81M -8.8M -12.05M -10.35M -8.25M -7.89M -3.37M -6.88M -8.33M -7.09M -8.87M -6.41M -5.97M -5.5M -2.4M -3.1M
EBIT
-10.19M -10.6M -10.3M -10.02M -9.89M -13.22M -11.62M -10.44M -9.91M -4.99M -8.1M -8.33M -7.09M -8.87M -6.41M -5.97M -5.5M -2.4M -3.1M
Depreciation & Amortization
1.2M 1.22M 1.21M 1.21M 1.09M 1.17M 1.27M 2.19M 2.02M 1.62M 1.23M 20.34K 18.89K 47.25K -39.84K -370.51K -243.85K -273.78K -177.26K